
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Perspectives
Keywords: اثربخشی هزینه; stroke prevention; atrial fibrillation; cost-effectiveness; cost-utility; dabigatran;